# Jai Radhakrishnan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jai-radhakrishnan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,170 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 72 |
| i10-index | 203 |
| Last Known Institution | Columbia University Irving Medical Center |
| OpenAlex ID | https://openalex.org/A5088037254 |
| ORCID iD | 0000-0003-3157-5141 |
| Works | 407 |

## Researcher papers

Showing 12 of 30.

- [KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/kdigo-2021-clinical-practice-guideline-for-the-management-of-glomerular-diseases/)
- [Pathologic Classification of Diabetic Nephropathy](https://scholariq.org/papers/pathologic-classification-of-diabetic-nephropathy/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Diagnostic Utility of Exome Sequencing for Kidney Disease](https://scholariq.org/papers/diagnostic-utility-of-exome-sequencing-for-kidney-disease/)
- [Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities](https://scholariq.org/papers/mutations-in-kelch-like-3-and-cullin-3-cause-hypertension-and-electrolyte/)
- [The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patient](https://scholariq.org/papers/the-kdigo-practice-guideline-on-glomerulonephritis-reading-between-the-guide/)
- [Toxic acute tubular necrosis following treatment with zoledronate (Zometa)](https://scholariq.org/papers/toxic-acute-tubular-necrosis-following-treatment-with-zoledronate-zometa/)
- [Acute Phosphate Nephropathy following Oral Sodium Phosphate Bowel Purgative](https://scholariq.org/papers/acute-phosphate-nephropathy-following-oral-sodium-phosphate-bowel-purgative/)
- [Presentation and Outcomes of Patients with ESKD and COVID-19](https://scholariq.org/papers/presentation-and-outcomes-of-patients-with-eskd-and-covid-19/)
- [Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis](https://scholariq.org/papers/eculizumab-for-dense-deposit-disease-and-c3-glomerulonephritis/)
- [Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities](https://scholariq.org/papers/tenofovir-nephrotoxicity-acute-tubular-necrosis-with-distinctive-clinical/)
- [The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes](https://scholariq.org/papers/the-modern-spectrum-of-renal-biopsy-findings-in-patients-with-diabetes/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Researcher university

- [Columbia University Irving Medical Center](https://scholariq.org/institutions/columbia-university-irving-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.